Please use this identifier to cite or link to this item:
Resource typeDissertation
Title(s)Selected Aspects of Biodegradation Testing of Pharmaceuticals Including Development of a New Biodegradation Test
Alternative title(s)Ausgewählte Aspekte von Tests auf biologische Abbaubarkeit von Pharmazeutika einschließlich der Entwicklung eines neuen Tests
CreatorBaginska, Ewelina  143826557
RefereeKümmerer, Klaus  0000-0003-2027-6488  118066382
Radke, Michael  1046241281
Pleissner, Daniel
AdvisorKümmerer, Klaus  0000-0003-2027-6488  118066382
AbstractAmong all attenuation processes, biodegradation plays one of the most important role and is one of the most desirable processes in the environment. To assess biodegradation, a variety of biodegradation test procedures have been developed by several international organizations. OECD guidelines for ready biodegradability testing represent one of the most prominent group of internationally used screening biodegradation tests (series 301A-F). These tests are usually very simple in their designs and allow for the fast and cheap screening of biodegradability. However, because of their stringency, the test conditions are not close to simulating environmental conditions and may lead to unrealistic results. To overcome these limitations, OECD introduced simulation tests which are designed to investigate the behavior of chemicals in specified environmentally relevant compartments. Despite the fact that simulation tests give more insight into the fate of chemicals in the environment, they are not applied frequently as they are often tedious, time consuming and expensive. Consequently, there is a need to provide a new biodegradation testing method that would combine complex testing environment as in simulation tests, easiness in handling and good data repeatability as in screening biodegradation tests. Another challenge is an adaption of the existing biodegradation testing methods to new types of samples, i.e. mixtures of transformation products (TPs). The research on the presence of pharmaceuticals in the environment gained momentum in the 1990s; since then, it has been growing. Their presence in the environment is a wellestablished fact. A wide range of pharmaceuticals is continuously detected in many environmental compartments such as surface waters, soils, sediments, or ground waters. After pharmaceuticals reach the natural aquatic environment they may undergo a number of processes such as: photolysis (under direct sunlight), hydrolysis, oxidation and reduction reactions, sorption, biodegradation (by bacteria of fungi), and bioaccumulation. These processes, may cause their elimination from aquatic environment, if reaction is complete, or creation of new compounds i.e., transformation products (TPs). What is more, processes, like chlorination and advanced oxidation processes (AOPs), such as H2O2/UV, O3/UV, TiO2/UV, Fenton, and photo-Fenton, or UV treatment which might be applied in water or wastewater treatment, may also lead to the TPs introduction into aquatic environment. The research on the TPs brings many new challenges. From one side, there is a constant need for the the development of a sensitive and reliable analytical separation, detection, and structure elucidation methods. Additionally, there is a need for the preparation of appropriate assays for the investigation of properties of new compounds, especially those answering the question if TPs pose a higher risk to the aquatic ecosystems than their parent compounds. Among numerous groups of pharmaceuticals, two are of great importance: antibiotics since they might promote emergence and maintenance of antimicrobial resistance in the aquatic environment; and cytostatic drugs. Cytostatic drugs can exert carcinogenic, mutagenic and/or teratogenic effects in animals and humans. The challenges of biodegradation testing presented in this thesis, encompasses these different areas of interest and was divided into three objectives: 1) Identification of the knowledge gaps and data distribution of the two groups of pharmaceuticals antibiotics and cytostatic drugs (article I); 2) Increasing the knowledge on biodegradation of cytostatic drugs and their TPs (articles II, III, and IV) and 3) Establishment of a biodegradation test with closer to simulation tests conditions, that could be affordable and to support better understanding on processes in water sediment interface construction - screening water-sediment test. Further validation of the test with an insight into sorption and desorption processes (articles V and VI).
KeywordsBiodegradability; Biologische Abbaubarkeit; Arzneimittel; Sediment; Antibiotikum; Pestizide
Date of defense2018-01-23
Year of publication in PubData2018
Publishing typeFirst publication
Date issued2018-01-26
Creation contextResearch
Granting InstitutionLeuphana Universität Lüneburg
Published byMedien- und Informationszentrum, Leuphana Universität Lüneburg
Files in This Item:
File SizeFormat 

MD5: 8550e407c8865437f2f89d31b82b757c
License:  Nutzung nach Urheberrecht

5.9 MB

Adobe PDF

Items in PubData are protected by copyright, with all rights reserved, unless otherwise indicated.

Citation formats
Access statistics

Page view(s): 12

Download(s): 3